Rotavirus is a leading cause of severe gastroenteritis and diarrhea globally, and nearly all children have been infected with ...

"The risk of the original rotavirus vaccine was pretty small, and it was still taken off the market out of an abundance of caution once it was identified that there was a concern ...

Safer and more broadly effective rotavirus vaccines could be achieved if initial investigations 1 into the boosting effect of plant-derived virus-like particles hold up in further trials.

Background and aims: Current rotavirus vaccines have showed outstanding effectiveness in USA, but data coming from Europe are still scarce. Effectiveness of rotavirus vaccination in Spain - where ...

Since licensure in 2006, the rotavirus vaccines, RV5 (pentavalent bovine-human reassortant vaccine, Rotateq, Merck) and RV1 (attenuated monovalent human rotavirus vaccine, Rotarix, GSK Biologicals ...

Expert Rev Vaccines. 2012;11(2):211-220. Immunogenicity studies alone will be insufficient to answer many of the questions regarding vaccine performance. Thus, if immunogenicity data suggest ...

A recent decrease in the incidence of type 1 diabetes in Australian children may be linked to the introduction of a routine vaccine against rotavirus, according to a study published yesterday (January ...

Kenya is facing an acute shortage of rotavirus vaccine risking a surge in diarrhea cases and deaths. The rotavirus vaccine is supplied through Kenya Expanded Programme on Immunisation (KEPI) and ...

America’s decision to terminate its funding of Gavi, the organisation which provides vaccines to the developing world, is short sighted in the extreme.